| 000 | 01797 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513130358.0 | ||
| 264 | 0 | _c19971124 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0041-008X | ||
| 024 | 7 |
_a10.1006/taap.1997.8230 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorley, T J | |
| 245 | 0 | 0 |
_aStructure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cOct 1997 |
||
| 300 |
_a299-308 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Proteins _xanalysis |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHydroxamic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aHydroxyurea _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
| 650 | 0 | 4 |
_aLipoxygenase Inhibitors _xtoxicity |
| 650 | 0 | 4 |
_aNephrosis, Lipoid _xchemically induced |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xblood |
| 650 | 0 | 4 |
_aProteinuria _xchemically induced |
| 650 | 0 | 4 |
_aPuromycin Aminonucleoside _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 | _aUrinalysis |
| 700 | 1 | _aEvans, G O | |
| 700 | 1 | _aGoodwin, D A | |
| 700 | 1 | _aRead, N G | |
| 700 | 1 | _aHodgson, S T | |
| 700 | 1 | _aHawksworth, G M | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 146 _gno. 2 _gp. 299-308 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/taap.1997.8230 _zAvailable from publisher's website |
| 999 |
_c9315965 _d9315965 |
||